ResearcherErasmus MCActive in the last 2 years
Lydi M.J.W. van Driel
Matched on ORCID iD 0000-0003-0616-7349; OpenAlex author ID A5044059419. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 35
2020: 2 papers · 2021: none · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper
Papers 7
- Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial. Co-author DOI 10.1001/jamasurg.2023.7872↗
- Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials. Last author DOI 10.1016/j.hpb.2023.04.018↗
- Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial. Co-author DOI 10.1186/s12885-023-11141-5↗
- Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. Co-author DOI 10.1016/j.gie.2022.04.1342↗
- Long-term yield of pancreatic cancer surveillance in high-risk individuals. Co-author DOI 10.1136/gutjnl-2020-323611↗
- Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled t… Co-author DOI 10.1186/s13063-020-4180-z↗
- Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic Cancer. Co-author DOI 10.14309/ajg.0000000000000939↗
Closest collaborators
The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marco J. Bruno · 4 shared papers, 2020–2023 · strength 0.53
- Paper Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. DOI 10.1016/j.gie.2022.04.1342↗
- Paper Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPA… DOI 10.1016/j.hpb.2023.04.018↗
- Paper Long-term yield of pancreatic cancer surveillance in high-risk individuals. DOI 10.1136/gutjnl-2020-323611↗
- Bas Groot Koerkamp · 3 shared papers, 2022–2023 · strength 0.39
- Paper Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPA… DOI 10.1016/j.hpb.2023.04.018↗
- Paper Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter r… DOI 10.1186/s12885-023-11141-5↗
- Paper Long-term yield of pancreatic cancer surveillance in high-risk individuals. DOI 10.1136/gutjnl-2020-323611↗
- Marc G. Besselink · 3 shared papers, 2022–2023 · strength 0.39
- Paper Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPA… DOI 10.1016/j.hpb.2023.04.018↗
- Paper Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter r… DOI 10.1186/s12885-023-11141-5↗
- Paper Long-term yield of pancreatic cancer surveillance in high-risk individuals. DOI 10.1136/gutjnl-2020-323611↗
- Casper H.J. van Eijck · 3 shared papers, 2022–2023 · strength 0.39
- Paper Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPA… DOI 10.1016/j.hpb.2023.04.018↗
- Paper Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter r… DOI 10.1186/s12885-023-11141-5↗
- Paper Long-term yield of pancreatic cancer surveillance in high-risk individuals. DOI 10.1136/gutjnl-2020-323611↗
- Iris J. M. Levink · 3 shared papers, 2020–2022 · strength 0.39
- Paper Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. DOI 10.1016/j.gie.2022.04.1342↗
- Paper Long-term yield of pancreatic cancer surveillance in high-risk individuals. DOI 10.1136/gutjnl-2020-323611↗
- Paper Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic … DOI 10.14309/ajg.0000000000000939↗
- Djuna L. Cahen · 3 shared papers, 2020–2022 · strength 0.39
- Paper Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. DOI 10.1016/j.gie.2022.04.1342↗
- Paper Long-term yield of pancreatic cancer surveillance in high-risk individuals. DOI 10.1136/gutjnl-2020-323611↗
- Paper Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic … DOI 10.14309/ajg.0000000000000939↗
- Brechtje D.M. Koopmann · 2 shared papers, 2022 · strength 0.28
- Johanna W. Wilmink · 2 shared papers, 2023 · strength 0.27
- Paper Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPA… DOI 10.1016/j.hpb.2023.04.018↗
- Paper Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter r… DOI 10.1186/s12885-023-11141-5↗
- Geertjan van Tienhoven · 2 shared papers, 2023 · strength 0.27
- Paper Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPA… DOI 10.1016/j.hpb.2023.04.018↗
- Paper Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter r… DOI 10.1186/s12885-023-11141-5↗
- Bert A. Bonsing · 2 shared papers, 2023 · strength 0.27
- Paper Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPA… DOI 10.1016/j.hpb.2023.04.018↗
- Paper Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter r… DOI 10.1186/s12885-023-11141-5↗
- Marjolein Y.V. Homs · 2 shared papers, 2023 · strength 0.27
- Paper Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPA… DOI 10.1016/j.hpb.2023.04.018↗
- Paper Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter r… DOI 10.1186/s12885-023-11141-5↗
- Gwenny Manel Fuhler · 2 shared papers, 2020–2022 · strength 0.27
- Jeanin Elise van Hooft · 2 shared papers, 2022–2023 · strength 0.27
- Isis J. Visser · 1 shared paper, 2022 · strength 0.16
- Michail Doukas · 1 shared paper, 2023 · strength 0.15
- Quisette P. Janssen · 1 shared paper, 2023 · strength 0.15
- Joanne Verheij · 1 shared paper, 2023 · strength 0.15
- Svein Olav Bratlie · 1 shared paper, 2023 · strength 0.12
- Izaak Quintus Molenaar · 1 shared paper, 2023 · strength 0.12
- Esther N. Dekker · 1 shared paper, 2023 · strength 0.12
- Jacob L. van Dam · 1 shared paper, 2023 · strength 0.12
- Marion B.M. van der Kolk · 1 shared paper, 2023 · strength 0.12
- Poya Ghorbani · 1 shared paper, 2023 · strength 0.12
- Judith de Vos‐Geelen · 1 shared paper, 2023 · strength 0.12
- Ignace H. J. T. de Hingh · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.